← Back
$PHAT All transactions

Phathom Pharmaceuticals, Inc.

A

$ Value

$0

Shares

10,500

Price

$0

Filed

Jun 5

Insider

Name

Stenhouse Mark

Title

CIK

0001734751

Roles

Director

Transaction Details

Transaction Date

2025-06-03

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

30,000

Footnotes

The Restricted Stock Units ("RSUs") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. | The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.

Filing Info

Accession No.

0000950170-25-082448

Form Type

4

Issuer CIK

0001783183

Stenhouse Mark's History

Date Ticker Type Value
2025-06-03 PHAT A $0
2025-06-03 PHAT A $0

Other Insiders at PHAT (90d)

Insider Bought Sold Last
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
2026-02-10
Basta Steven L
President and CEO
2026-02-10
Parikh Asit 2026-03-10
Breedlove Robert Charles
Principal Accounting Officer
2026-02-27